Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01823562 · ClinicalTrials.gov registry record · Phase 1
Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery
A Phase 1 study of Stage I Prostate Cancer and Stage III Prostate Cancer, sponsored by Ohio State University Comprehensive Cancer Center.
- Active
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT01823562: Active Phase 1 study of Stage I Prostate Cancer and Stage III Prostate Cancer, sponsored by Ohio State University Comprehensive Cancer Center.
NCT01823562 is a Phase 1 study of Stage I Prostate Cancer and Stage III Prostate Cancer that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 56 participants, roughly in line with the 54-participant average among 9 other Stage I Prostate Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01823562, a Phase 1 study of Stage I Prostate Cancer and Stage III Prostate Cancer, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
This Phase I/Ib trial is studying the absorption and metabolism of phytochemicals found in black raspberries in men undergoing surgery for prostate cancer. This knowledge will help us design future chemoprevention studies and assist in making future dietary recommendations for men at high risk for prostate cancer.
Primary Outcome
Adverse events were measured by asking participants at each study visit about any new symptoms which may or may not be related to the intervention. No adverse events were reported from any subjects.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- PROCEDURE quality-of-life assessment
- DIETARY_SUPPLEMENT dietary intervention
- DRUG lyophilized black raspberry confection
Study Locations (1)
Ohio
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2012-10-17 |
| Est. Completion | 2025-06 |
| Phase | Phase 1 |
What the registry record for NCT01823562 still lists
NCT01823562 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, roughly in line with the 54-participant average among 9 other Stage I Prostate Cancer trials with a reported enrollment target.
The record links to 4 conditions, with Stage I Prostate Cancer appearing as the primary indexed condition, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT01823562 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01823562 about?
NCT01823562 is a clinical study titled "Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery". This Phase I/Ib trial is studying the absorption and metabolism of phytochemicals found in black raspberries in men undergoing surgery for prostate cancer. This knowledge will help us design future chemoprevention studies and assist in making future dietary recommendations for men at high risk for p...
What is the current status of trial NCT01823562?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2012-10-17. Estimated completion is 2025-06.
What conditions does trial NCT01823562 study?
This clinical trial studies the following conditions: Stage I Prostate Cancer, Stage III Prostate Cancer, Stage IIB Prostate Cancer, Stage IIA Prostate Cancer.
What interventions are being tested in trial NCT01823562?
The interventions under investigation include: laboratory biomarker analysis (OTHER), quality-of-life assessment (PROCEDURE), dietary intervention (DIETARY_SUPPLEMENT), lyophilized black raspberry confection (DRUG).
Who is sponsoring clinical trial NCT01823562?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01823562 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage I Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01823562's enrollment target sits among peer trials
56 3rd of 9 higher than 7 of 9 other Stage I Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stage I Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery
ACTIVE NOT RECRUITING · Phase 1
-
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
RECRUITING · NA
-
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
Researching the Effect of Exercise on Cancer
ACTIVE NOT RECRUITING · NA
-
Visually Enhanced Education About Prostate Cancer
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI